Financial results - BIOEXPLOMED S.R.L.

Financial Summary - Bioexplomed S.r.l.
Unique identification code: 17595426
Registration number: J35/1657/2005
Nace: 8690
Sales - Ron
171.016
Net Profit - Ron
13.207
Employees
4
Open Account
Company Bioexplomed S.r.l. with Fiscal Code 17595426 recorded a turnover of 2024 of 171.016, with a net profit of 13.207 and having an average number of employees of 4. The company operates in the field of Alte activitati referitoare la sanatatea umana having the NACE code 8690.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Bioexplomed S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 144.969 129.017 - 127.197 187.903 113.310 152.381 205.412 172.268 171.016
Total Income - EUR 162.894 144.559 - 132.105 237.926 116.275 155.232 207.413 176.714 191.996
Total Expenses - EUR 160.600 136.186 - 123.137 229.822 91.764 141.616 176.274 160.710 173.893
Gross Profit/Loss - EUR 2.294 8.373 - 8.968 8.104 24.511 13.616 31.139 16.004 18.103
Net Profit/Loss - EUR 1.927 7.033 - 7.695 5.725 23.827 12.095 30.032 14.502 13.207
Employees 0 0 - 8 8 5 5 5 5 4
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -0.2%, from 172.268 euro in the year 2023, to 171.016 euro in 2024. The Net Profit decreased by -1.214 euro, from 14.502 euro in 2023, to 13.207 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Bioexplomed S.r.l.

Rating financiar

Financial Rating -
BIOEXPLOMED S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Bioexplomed S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Bioexplomed S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Bioexplomed S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Bioexplomed S.r.l. - CUI 17595426

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 91.204 69.832 - 24.880 84.864 71.444 32.855 42.901 27.343 22.617
Current Assets 54.196 69.796 - 126.626 143.349 178.796 166.696 177.373 96.663 142.724
Inventories 877 868 - 64.797 23.709 76.238 82.319 85.973 2.748 53.462
Receivables 46.119 51.863 - 57.368 113.869 92.980 62.750 88.688 90.988 83.662
Cash 7.200 17.064 - 4.461 5.771 9.578 21.627 2.712 2.927 5.599
Shareholders Funds 22.382 29.187 - 17.816 23.196 45.684 33.467 63.604 87.487 110.278
Social Capital 112 111 - 107 105 103 101 101 101 101
Debts 76.450 121.699 - 133.477 207.309 198.805 157.053 147.612 127.061 160.018
Income in Advance 54.155 38.062 - 16.865 16.539 16.225 15.865 15.914 15.866 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8690 - 8690"
CAEN Financial Year 8690
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 142.724 euro in 2024 which includes Inventories of 53.462 euro, Receivables of 83.662 euro and cash availability of 5.599 euro.
The company's Equity was valued at 110.278 euro, while total Liabilities amounted to 160.018 euro. Equity increased by 23.280 euro, from 87.487 euro in 2023, to 110.278 in 2024.

Risk Reports Prices

Reviews - Bioexplomed S.r.l.

Comments - Bioexplomed S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.